Trials / Active Not Recruiting
Active Not RecruitingNCT05267340
Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 14 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective will be to study changes in putamen connectivity and depression severity in depressed teens with meditation training. H1: Putamen node strength will increase in the training group compared to the active controls. H2: This increase in node strength will correlate with practice amount recorded by participants. H3: There will be a significant reduction in self-rated depression symptoms following the training as measured by the Reynolds Adolescent Depression Scale (RADS-2), compared to controls. H4: This reduction will correlate with the increase in putamen node strength. Design and Outcomes: The current research study design will utilize an individually randomized group treatment, open-label, active-controlled clinical trial to test the efficacy and safety of the investigator's innovative mindfulness meditation intervention (Training for Awareness Resilience and Action \[TARA\]) on the primary outcome (Putamen structural node strength) and secondary outcome (depression symptoms measured using Reynolds Adolescent Depression Scale \[RADS-2\]) in depressed adolescents between the ages of 14 to 18 years old.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | TARA | This will be a 12-week group meditation training - Training for Awareness, Resilience, and Action (TARA) |
| BEHAVIORAL | Psycho-Education | This will be a 12-week group meditation training - Training for Awareness, Resilience, and Action (TARA) without the mindfulness meditation components |
Timeline
- Start date
- 2023-02-08
- Primary completion
- 2026-08-31
- Completion
- 2026-08-31
- First posted
- 2022-03-04
- Last updated
- 2026-03-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05267340. Inclusion in this directory is not an endorsement.